---
title: "Dinutuximab - Neuroblastoma"
sidebar: mydoc_sidebar
permalink: db09077-mesh-d009447-1.html
toc: false 
---


Path ID: `DB09077_MESH_D009447_1`
{% include image.html url="images/db09077-mesh-d009447-1.png" file="db09077-mesh-d009447-1.png" alt="db09077-mesh-d009447-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| DB:DB09077 | dinutuximab | Drug |
| CHEBI:28648 | β-D-GalNAc-(1→4)-[α-Neu5Ac-(2→8)-α-Neu5Ac-(2→3)]-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer | ChemicalSubstance |
| CL:0001063 | neoplastic cell | Cell |
| GO:0001913 | T cell mediated cytotoxicity | BiologicalProcess |
| GO:0097278 | complement-dependent cytotoxicity | BiologicalProcess |
| MESH:D009447 | Neuroblastoma | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Dinutuximab | MOLECULARLY INTERACTS WITH | Β-D-Galnac-(1→4)-[Α-Neu5Ac-(2→8)-Α-Neu5Ac-(2→3)]-Β-D-Gal-(1→4)-Β-D-Glc-(1↔1')-Cer |
| Β-D-Galnac-(1→4)-[Α-Neu5Ac-(2→8)-Α-Neu5Ac-(2→3)]-Β-D-Gal-(1→4)-Β-D-Glc-(1↔1')-Cer | LOCATED IN | Neoplastic Cell |
| Neoplastic Cell | LOCATION OF | T Cell Mediated Cytotoxicity |
| Neoplastic Cell | LOCATION OF | Complement-Dependent Cytotoxicity |
| T Cell Mediated Cytotoxicity | NEGATIVELY CORRELATED WITH | Neuroblastoma |
| Complement-Dependent Cytotoxicity | NEGATIVELY CORRELATED WITH | Neuroblastoma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00531](https://go.drugbank.com/drugs/DB00531)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137342/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3137342/)
  - [https://en.wikipedia.org/wiki/Dinutuximab#Pharmacology](https://en.wikipedia.org/wiki/Dinutuximab#Pharmacology)
